This month, the U.S. Judicial Panel on Multidistrict Litigation (JPML) will determine whether more than fifty product liability lawsuits alleging Byetta and Januvia caused pancreatic cancer should be consolidated into multidistrict litigation (MDL) proceedings. The JPML will hear oral arguments for and against consolidating Byetta, Janumet,... Read More

Designed to help type 2 diabetics control their blood glucose levels, prescription medications Byetta and Januvia have been blamed for pancreatic diseases in some patients, spurring a litany of claims against the drug manufacturers. Clinical studies and adverse event reports have demonstrated a causal link... Read More